Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
US7807155 | NA | IL-17 antagonistic antibodies |
Feb, 2030
(6 years from now) |
Ingredients: SECUKINUMAB
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic